Birgitta Gullstrand
51 – 60 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Influence of IgG allotypes on defense against Haemophilus influenzae type b in children-A complement-dependent mechanism?
2009) 12th European Meeting on Complement in Human Disease In Molecular Immunology 46(14). p.2867-2868(
- Contribution to journal › Published meeting abstract
-
Mark
Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cells.
(
- Contribution to journal › Article
- 2008
-
Mark
Complement classical pathway components are all important in clearance of apoptotic cells
(
- Contribution to journal › Published meeting abstract
-
Mark
Role of C1q in regulation of IFN-alpha production
2008) 72nd Annual Scientific Meeting of the American-College-of-Rheumatology/43rd Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals In Arthritis and Rheumatism 58(9). p.706-706(
- Contribution to journal › Published meeting abstract
-
Mark
SLE serum induces classical caspase-dependent apoptosis independent of death receptors
(
- Contribution to journal › Article
-
Mark
Serum bactericidal activity against Neisseria meningitidis in patients with C3 nephritic factors is dependent on IgG allotypes.
(
- Contribution to journal › Article
- 2007
-
Mark
Genetically determined mannan-binding lectin deficiency is of minor importance in determining susceptibility to severe infections and vascular organ damage in systemic lupus erythematosus.
(
- Contribution to journal › Article
-
Mark
Association between SLE nephritis and polymorphic variants of the CRP and Fc gamma RIIIa genes
(
- Contribution to journal › Article
- 2004
-
Mark
Induction of apoptosis in monocytes and lymphocytes by serum from patients with systemic lupus erythematosus - an additional mechanism to increased autoantigen load?
(
- Contribution to journal › Article
- 2003
-
Mark
Cystic fibrosis patients heterozygous for MASP-2 gene mutation have lowered MASP-2 concentration, without relation to clinical findings
2003) 9th European Meeting on Complement in Human Disease In Molecular Immunology 40(2-4). p.208-208(
- Contribution to journal › Published meeting abstract